(Press-News.org) DURHAM, N.C. - Despite legal and ethical mandates for disclosure, results from most clinical trials of medical products are not reported promptly on a registry specifically created to make results of human studies publically available, according to Duke Medicine researchers.
Among all clinical trials of medical products, those funded by industry were the most likely to be publicly disclosed in a timely fashion, but even then, compliance was poor. Research funded by the National Institutes of Health and academic institutions lagged further, according to findings published by Duke Medicine researchers in the March 12, 2015, issue of the New England Journal of Medicine.
Study authors said the lack of transparency by industry, federal funders and academia has created a critical information gap about investigational drugs, devices and biologic therapies that not only hampers progress, but also violates obligations to patients.
"Patients who participate in clinical research have the expectation that the risk of participation will be offset by the creation of generalizable knowledge and the advancement of science, and that is achieved through the availability of clinical trial results," said lead author Monique Anderson, M.D., cardiologist and researcher at the Duke Clinical Research Institute. "Sponsors who lead clinical trials have an ethical and legal obligation to publically report their findings, whether the results are positive or negative.
In 2000, Congress authorized the creation of the ClinicalTrials.gov registry to provide information about clinical trials. Seven years later, the mandate expanded to require sponsors of most trials to begin registering and reporting basic summary results on the registry so the America public could have access to the resulting data.
The requirement covers non-phase-1 trials of drugs, medical devices, or biologics that had at least one U.S. research site. Trial results were to be reported by the sponsor within one year of completing data collection.
Anderson and colleagues found that in the first five years after the law's enactment, transparency has generally been poor among more than 13,000 clinical trials included in their analysis.
The Duke researchers examined studies from those listed on ClinicalTrials.gov, and found that an average of just 13.4 percent of eligible trials reported findings within the required one-year window.
For industry-sponsored trials, the rate was 17 percent. It was 5.7 percent for trials funded by academic or government sources other than the NIH and 8.1 percent for NIH-funded trials.
Compliance improved over time. At five years, 41.5 percent of industry-funded trials, 27.7 percent of academic/non-NIH-funded trials, and 38.9 percent of NIH-funded trials had reported results.
"The public, as well as health care providers, want 'open science,'" said Eric Peterson, M.D., executive director of the Duke Clinical Research Institute and co-author of the paper. "This study demonstrates that despite national laws, industry- and especially NIH-sponsored trials have a long way to go."
Among the studies in the analysis, nearly 85 percent were designed to investigate a new treatment, about 8 percent tested a prevention therapy, and the rest were for diagnostic tools. Two-thirds of the trials were funded by industry, followed by academic/non-NIH sources and the NIH.
"The law requiring public disclosure was enacted amid concerns that sponsors and investigators were selectively publishing trials that favored sponsors' interests," Anderson said. "Industry sponsors in particular were criticized for selective reporting. Since the law's enactment, many companies have developed disclosure policies and have actively pursued expanded public disclosure of data, but there may be a lack of knowledge about the law in academia, or a lack of resources to ensure timely reporting."
Anderson said penalties for failing to submit data within the one-year reporting period could be as high as $10,000 a day and/or the loss of NIH funding, but enforcement has not occurred, pending a rule approval.
INFORMATION:
In addition to Anderson and Peterson, study authors include Karen Chiswell; Asba Tasneem; James Topping; and Robert M. Califf (prior to his departure from Duke to join the Food and Drug Administration).
The Clinical Trials Transformation Initiative provided funding support, along with the National Institutes of Health Common Fund (3U54AT007748-02S1) and the Health Care Systems Research Collaboratory Coordinating Center via the National Institutes of Health (1U54AT007748-01, 3U54AT007748-02S1).
New research has shown that patients having heart surgery do not benefit if doctors wait until a patient has become substantially anaemic before giving a transfusion.
In the UK, about half of all patients having cardiac surgery are given a red blood cell transfusion after the operation, using up to ten per cent of the nation's blood supply. The proportion of patients having a transfusion is high because blood loss and severe anaemia are common after cardiac surgery and transfusion is the preferred treatment. Blood loss causes anaemia which doctors detect by measuring ...
MINNEAPOLIS - Older people who are physically active may be protecting themselves from the effects of small areas of brain damage that can affect their movement abilities, according to a new study published in the March 11, 2015, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Many older people have small areas of damage in their brains seen on magnetic resonance imaging (MRI) as white matter hyperintensities. Higher levels of this damage have been linked to more problems with movement, such as difficulty walking. But this new ...
The origin of life is still a mystery with many unsolved puzzles. How were molecules created? How did they assemble into large structures? Among the conundrums, the "homochirality" phenomenon upon which amino acids and sugars form is particularly fascinating. University of Akron A. Schulman Professor of Polymer Science Tianbo Liu has discovered that Mother Nature's clear bias toward certain amino acids and sugars and against others isn't accidental.
Liu explains that all life molecules are paired as left-handed and right-handed structures. In scientific terms, the phenomenon ...
COLUMBUS, Ohio - A new study has identified a group of molecules in prostate-cancer cells that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels indicate their cancer has recurred after surgical removal of the prostate.
Led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), the retrospective study suggested that a pattern of molecules called microRNA (miRNA) in tumor cells might predict patients' ...
A team of scientists from the Smithsonian's National Museum of Natural History gained new understanding about the evolutionary history of whale hearing thanks to a rare collection of whales at the museum. The researchers used noninvasive biomedical imaging techniques to trace the development of fetal ear bones in 56 specimens from 10 different families of toothed and baleen whales. They observed how ears develop in unborn whales of modern species, and compared these changes with those reflected in the fossilized ears of extinct whales over the course of millions of years. ...
A new study by University of Alberta law researchers reveals sometimes overly optimistic news coverage of clinical translation of stem cell therapies--and as spokespeople, scientists need to be mindful of harnessing public expectations.
"As the dominant voice in respect to timelines for stem cell therapies, the scientists quoted in these stories need to be more aware of the importance of communicating realistic timelines to the press," said researcher Kalina Kamenova, who co-authored the study with professor Timothy Caulfield in the University of Alberta's Health Law ...
DURHAM, N.C. - An innovative approach using a tetanus booster to prime the immune system enhances the effect of a vaccine therapy for lethal brain tumors, dramatically improving patient survival, according to a study led by Duke Cancer Institute researchers.
Appearing online March 11, 2015, in the journal Nature, the researchers not only present survival data for a small, randomized and blinded patient trial, they also detail how the tetanus pre-conditioning technique works, providing a roadmap for enhancing dendritic cell immunotherapies that have shown promise ...
A puzzling observation, pursued through hundreds of experiments, has led Stanford researchers to a simple yet profound discovery: under certain circumstances, droplets of fluid will move like performers in a dance choreographed by molecular physics.
"These droplets sense one another, they move and interact, almost like living cells," said Manu Prakash, an assistant professor of bioengineering and senior author of an article published (today) in Nature.
The unexpected findings may prove useful in semiconductor manufacturing and self-cleaning solar panels, but what truly ...
DURHAM, N.C. -- The molecular machines that copy DNA in a living cell are amazingly fast and accurate at pairing up the correct bases -- G with C and A with T -- into each new double helix.
They work by recognizing the shape of the right base pair combinations, and discarding those -- such as a G and a T -- that don't fit together correctly. Yet for approximately every 10,000 to 100,000 bases copied, these machines make a mistake that if uncorrected will be immortalized in the genome as a mutation.
For decades, researchers have wondered how these seemingly random ...
Bacteria that live on iron were found for the first time at three well-known vent sites along the Mid-Atlantic Ridge, one of the longest undersea mountain ranges in the world. Scientists report that these bacteria likely play an important role in deep-ocean iron cycling, and are dominant members of communities near and adjacent to sulfur-rich, black-smoker hydrothermal vents prevalent along the Mid-Atlantic Ridge. These unique chemosynthetic communities live off the chemical components in the vent fluid, rather than sunlight used by their photosynthetic counterparts. This ...
